Coronavirus
fromArs Technica
2 months agoRFK Jr. yanks pandemic vaccine funding as Moderna reports positive results
The HHS canceled funding for Moderna's mRNA flu vaccine due to safety concerns and the need for more testing.
Scientists have pursued a universal influenza vaccine for decades to protect against various strains, with recent plans for $500 million in funding marking significant progress.